What is aTyr Pharma's increase (decrease) in other receivables?

aTyr Pharma (ATYR) reported increase (decrease) in other receivables of -$396K in Q1 2026.

How has aTyr Pharma's increase (decrease) in other receivables changed year-over-year?

aTyr Pharma's increase (decrease) in other receivables increased by 47.1% year-over-year, from -$748K to -$396K.

aTyr Pharma ATYR Increase (Decrease) in Other Receivables

Increase (Decrease) in Other Receivables at other companies

ADTRAN Holdings, Inc.ADTN

$3.31M+190%

Willdan GroupWLDN

-$3.47M-296%

ACM ResearchACMR

$406K+106%

Mission Produce, Inc.AVO

-$1.1M+71.8%

State StreetSTT

$313M+26.7%

Moelis & CompanyMC

-$347K-102%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's increase (decrease) in other receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's increase (decrease) in other receivables?: aTyr Pharma (ATYR) reported increase (decrease) in other receivables of -$396K in Q1 2026.
How has aTyr Pharma's increase (decrease) in other receivables changed year-over-year?: aTyr Pharma's increase (decrease) in other receivables increased by 47.1% year-over-year, from -$748K to -$396K.